ALEXANDRIA, Va., April 8, 2021 /PRNewswire/ -- MellingMedical today announced a new distribution agreement with Optomed Plc, inventors of a state-of-the-art, handheld fundus camera that is changing the way ophthalmologists examine patients with diabetes. Under the agreement, MellingMedical will deliver Optomed's Aurora IQ camera to federal health facilities across the country.
“This device is practically tailor-made for the pandemic-driven expansion of telemedicine at federal health care facilities,“ said Chris Melling, founder and CEO of MellingMedical. “Its ease of use and digital connectivity can empower eye experts to conduct virtual eye exams wherever a camera can go, even if they can't be in the same room. Innovations like these are driving the improvement of care across the entire federal health system.“
MellingMedical will deliver Optomed's Aurora IQ camera to federal health facilities across the country.
Now available in all States and territories, Optomed's FDA-approved fundus camera is a great technology delivering tremendous value with enhanced and flexible workow options combined with quality documentation and seamless connectivity.